CAS: 74226-22-5 - 4-[2-(1H-Imidazol-1-yl)ethoxy]benzoic acid monohydrochloride
Formula:C12H13ClN2O3
InChI:InChI=1S/C12H12N2O3.ClH/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14;/h1-6,9H,7-8H2,(H,15,16);1H
InChI key:InChIKey=PVKDFUXBDJPRGU-UHFFFAOYSA-N
SMILES:Cl.O=C(O)C1=CC=C(OCCN2C=NC=C2)C=C1
- Synonyms:
- 1-[2-(4-Carboxyphenoxy)ethyl]imidazole monohydrochloride
- 4-[2-(1H-imidazol-1-yl)ethoxy]benzoic acid hydrochloride (1:1)
- Benzoic acid, 4-[2-(1H-imidazol-1-yl)ethoxy]-, hydrochloride (1:1)
- Benzoic acid, 4-[2-(1H-imidazol-1-yl)ethoxy]-, monohydrochloride
- Dazoxiben hydrochloride
- Dazoxiben monohydrochloride
- Uk 37248
- Uk-37248-01
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
UK-37248 REF: AN-AG00G23ICAS: 74226-22-5 | 98% | 162.00 €~1,099.00 € | Thu 09 May 24 | |
Dazoxiben REF: TM-T7968CAS: 74226-22-5 | 99.94% | 46.00 €~774.00 € | Thu 16 May 24 | |
4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride REF: 3D-ZCA22622CAS: 74226-22-5 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG00G23I
5mg | 162.00 € | |
25mg | 608.00 € | |
50mg | 688.00 € | |
100mg | 1,099.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Dazoxiben
CAS:74226-22-5
Dazoxiben (UK-37248) is a potent inhibitor of thromboxane (TX) synthase
Formula:
C12H13ClN2O3
Purity:
99.94%
Color and Shape:
Solid
Molecular weight:
268.7
Ref: TM-T7968
1mg | 46.00 € | |
2mg | 61.00 € | |
5mg | 90.00 € | |
10mg | 149.00 € | |
25mg | 301.00 € | |
50mg | 537.00 € | |
100mg | 774.00 € | |
1ml*10 (DMSO) | 58.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride
CAS:74226-22-5
4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride is a fatty acid synthetase inhibitor that inhibits the synthesis of long …
Formula:
C12H13ClN2O3
Purity:
Min. 95%
Molecular weight:
268.69 g/mol
Ref: 3D-ZCA22622
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024